{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.

RSS Feed for NewMediaWire

45Drives Announced as Platinum Sponsor of Cephalocon 2025

October 8, 2025Technical Director Brett Kelly to Deliver Keynote on Ceph’s Future in the Era of High-Performance Storage SYDNEY, NOVA SCOTIA and WILMINGTON, NC - October 8, 2025 (NEWMEDIAWIRE) - 45Drives, a global leader in open-source storage hardware and enterprise data infrastructure solutions, today announced its Platinum Sponsorship of Cephalocon 2025, taking place October 28–29, 2025, at the Vancouver Convention Center in Vancouver, Canada. As a leading advocate for open-source innovation, 45Drives will showcase its latest high-performance server technologies, including the NVMe Stornado F16, the Storinator Hybrid, and its latest Ceph gateway server hardware - all designed to optimize performance, scalability, and flexibility for enterprise Ceph deployments.


ABVC BioPharma Has Received a Cumulative Total of US$566,000 Under ForSeeCon Licensing Agreement Supporting GMP Facility in Hsinchu for Vitargus® Production

October 8, 2025SILICON VALLEY, CA - October 8, 2025 (NEWMEDIAWIRE) - ABVC BioPharma, Inc. (NASDAQ: ABVC) (“ABVC” or the “Company”) today announced that it has received a US$70,000 licensing payment from its partner, ForSeeCon Eye Corporation (“ForSeeCon”), under their global licensing agreement for Vitargus®, the world’s first biodegradable vitreous substitute.


Datavault AI (DVLT) Expands Into Sports and Esports Through Strategic Partnerships

October 7, 2025LOS ANGELES, CA - October 7, 2025 (NEWMEDIAWIRE) - Datavault AI (NASDAQ: DVLT), a leader in AI-driven data visualization, valuation, and monetization, announced new partnerships with Cutting Edge Sports Management and FN Esports to integrate its technologies across sports and entertainment. The collaborations will power tokenized sponsorships, blockchain-based athlete selection, and VerifyU(R)-enabled credentialing for Dream Bowl XIV, set for Jan.


Beeline Holdings (BLNE) Bullish About Millennials and Gen Z Lendable Market; Floats AI-Powered Mortgage and Loans Product

October 7, 2025LOS ANGELES, CA - October 7, 2025 (NEWMEDIAWIRE) - Beeline Holdings (NASDAQ: BLNE), a technology-forward mortgage and title platform that leverages AI, automation, and intuitive user experiences to simplify home financing, continues to focus on millennial and Gen Z markets for home purchases. As a market comprising over 100 million individuals, Beeline recognizes that the preferences of this demographic differ significantly from those of the average customer.


Hybrid Power Solutions Secures Major Advance Purchase Order Worth Over $1 Million

October 7, 2025Powering Construction, Restoration, and Events With Innovative Clean Energy Solutions TORONTO, ONTARIO - October 7, 2025 (NEWMEDIAWIRE) - Hybrid Power Solutions Inc. (CSE: HPSS) (OTC: HPSIF) (FSE: E092) ("Hybrid" or the "Company") is pleased to announce the signing of an advance purchase order (“PO”) at an MSRP value of $1,173,800 with LMDH Equipment Sales Inc.


AXIM Biotechnologies Announces Exclusive Latin America License & Distribution Agreement With JK Medical for TearScan® Ocular Diagnostic Tests

October 7, 2025Countries: Brazil, Chile, Peru, Argentina, Mexico, Ecuador, Colombia SAN DIEGO, CA - October 7, 2025 (NEWMEDIAWIRE) - AXIM Biotechnologies, Inc. (OTC: AXIM), a diagnostics company focused on rapid, point-of-care ophthalmic testing, today announced it has entered into an exclusive license and distribution agreement with JK Medical, Inc.


GeoVax to Participate in the 4th Annual ROTH Healthcare Opportunities Conference

October 7, 2025David Dodd, Chairman & CEO, Available for Investor Meetings ATLANTA, GA - October 7, 2025 (NEWMEDIAWIRE) - GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today announced that its Chairman and CEO, David Dodd, will participate in the 4th Annual ROTH Healthcare Opportunities Conference, taking place on Thursday, October 9, 2025, at the Yale Club in New York City.


Avant Capital Closes Three Builder Inventory Loans Totaling $7.95 Million in Florida, New York, Texas and Puerto Rico

October 7, 2025NEW CANAAN, CT - October 7, 2025 (NEWMEDIAWIRE) - Avant Capital (“Avant”), a leading Connecticut-based commercial real estate bridge lender, today announced that it has closed three separate builder inventory loans totaling $7,950,000. The loans, secured by condominium, co-op and residential portfolios across Florida, New York, Texas and Puerto Rico, reflect Avant’s continued focus on providing flexible capital solutions for sponsors with individually deeded residential assets.


CHARBONE Hydrogen Secures Harnois Energies' Hydrogen Assets to Accelerate Clean Ultra High Purity Hydrogen Production at Sorel-Tracy

October 7, 2025BROSSARD, QUEBEC - October 7, 2025 (NEWMEDIAWIRE) - CHARBONE HYDROGEN CORPORATION (TSXV: CH; OTCQB: CHHYF; FSE: K47) (“CHARBONE” or the “Company”), a company dedicated to building a North America’s first clean Ultra High Purity (“UHP”) hydrogen production and distribution network, is pleased to announce that it has officially taken possession of hydrogen production and refuelling assets from Harnois Energies Inc. (“Harnois”).


NeuroOne Announces Preliminary Unaudited Product Revenue Growth of 163% to Record $9.1 Million, Invitation to Join Virtual Investor Webinar Tomorrow at 8:30 am EST

October 6, 2025EDEN PRAIRIE, MINN. - October 6, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced preliminary unaudited product revenue for the fiscal year ended September 30, 2025.